Matthew C.  Wallis net worth and biography

Matthew Wallis Biography and Net Worth

COO of IMAC
Director, Chief Operating Officer & Co-founder of IMAC Holdings since March 2015. Wallis is the Founder of IMAC Regeneration Center of Kentucky which opened in August 2000 and has been a licensed chiropractor in Kentucky since 1998, during which he established the first Integrated Medicine and Chiropractic ("IMAC") Regeneration Center. During this time, Wallis has implemented consistent operating efficiencies for all IMAC clinics. Wallis holds a Doctor of Chiropractic (DC) degree from Life University.

What is Matthew C. Wallis' net worth?

The estimated net worth of Matthew C. Wallis is at least $2.12 million as of April 7th, 2021. Dr. Wallis owns 1,751,694 shares of IMAC stock worth more than $2,119,550 as of December 22nd. This net worth approximation does not reflect any other investments that Dr. Wallis may own. Additionally, Dr. Wallis receives a salary of $289,830.00 as COO at IMAC. Learn More about Matthew C. Wallis' net worth.

How old is Matthew C. Wallis?

Dr. Wallis is currently 48 years old. There are 3 older executives and no younger executives at IMAC. The oldest executive at IMAC is Dr. Ben Lerner, Chief Operating Officer, who is 55 years old. Learn More on Matthew C. Wallis' age.

What is Matthew C. Wallis' salary?

As the COO of IMAC Holdings, Inc., Dr. Wallis earns $289,830.00 per year. The highest earning executive at IMAC is Mr. Jeffrey S. Ervin M.B.A., Chairman & CEO, who commands a salary of $377,690.00 per year. Learn More on Matthew C. Wallis' salary.

How do I contact Matthew C. Wallis?

The corporate mailing address for Dr. Wallis and other IMAC executives is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. IMAC can also be reached via phone at (844) 266-4622 and via email at [email protected]. Learn More on Matthew C. Wallis' contact information.

Has Matthew C. Wallis been buying or selling shares of IMAC?

Matthew C. Wallis has not been actively trading shares of IMAC within the last three months. Most recently, Matthew C. Wallis sold 400,000 shares of the business's stock in a transaction on Wednesday, April 7th. The shares were sold at an average price of $1.60, for a transaction totalling $640,000.00. Following the completion of the sale, the chief operating officer now directly owns 1,751,694 shares of the company's stock, valued at $2,802,710.40. Learn More on Matthew C. Wallis' trading history.

Who are IMAC's active insiders?

IMAC's insider roster includes Michael Pruitt (Director), and Matthew Wallis (COO). Learn More on IMAC's active insiders.

Matthew C. Wallis Insider Trading History at IMAC

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/7/2021Sell400,000$1.60$640,000.001,751,694View SEC Filing Icon  
See Full Table

Matthew C. Wallis Buying and Selling Activity at IMAC

This chart shows Matthew C Wallis's buying and selling at IMAC by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

IMAC Company Overview

IMAC logo
IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.
Read More

Today's Range

Now: $1.21
Low: $1.12
High: $1.32

50 Day Range

MA: $1.15
Low: $1.01
High: $1.39

2 Week Range

Now: $1.21
Low: $0.75
High: $1.65

Volume

68,696 shs

Average Volume

708,132 shs

Market Capitalization

$32.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A